APOBEC proteins and intrinsic resistance to HIV-1 infection

被引:210
|
作者
Malim, Michael H. [1 ]
机构
[1] Kings Coll London, Guys Hosp, Sch Med, Dept Infect Dis, London SE1 9RT, England
基金
英国医学研究理事会;
关键词
HIV-1; APOBEC3G; Vif; hypermutation; reverse transcription; HUMAN-IMMUNODEFICIENCY-VIRUS; BLOOD MONONUCLEAR-CELLS; RNA-EDITING ENZYME; POLYPEPTIDE-LIKE; 3G; TO-A MUTATION; CYTIDINE DEAMINASE; TYPE-1; VIF; REVERSE TRANSCRIPTION; ANTIRETROVIRAL FACTOR; ANTIVIRAL ACTIVITY;
D O I
10.1098/rstb.2008.0185
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Members of the APOBEC family of cellular polynucleotide cytidine deaminases, most notably APOBEC3G and APOBEC3F, are potent inhibitors of HIV-1 infection. Wild type HIV-1 infections are largely spared from APOBEC3G/F function through the action of the essential viral protein, Vif. In the absence of Vif, APOBEC3G/F are encapsidated by budding virus particles leading to excessive cytidine (C) to uridine (U) editing of negative sense reverse transcripts in newly infected cells. This registers as guanosine (G) to adenosine (A) hypermutations in plus-stranded cDNA. In addition to this profoundly debilitating effect on genetic integrity, APOBEC3G/F also appear to inhibit viral DNA synthesis by impeding the translocation of reverse transcriptase along template RNA. Because the functions of Vif and APOBEC3G/F proteins oppose each other, it is likely that fluctuations in the Vif-APOBEC balance may influence the natural history of HIV-1 infection, as well as viral sequence diversification and evolution. Given Vif's critical role in suppressing APOBEC3G/F function, it can be argued that pharmacologic strategies aimed at restoring the activity of these intrinsic anti-viral factors in the context of infected cells in vivo have clear therapeutic merit, and therefore deserve aggressive pursuit.
引用
收藏
页码:675 / 687
页数:13
相关论文
共 50 条
  • [23] Biochemical differentiation of APOBEC3F and APOBEC3G proteins associated with HIV-1 life cycle
    Wang, Xiaojun
    Dolan, Patrick T.
    Dang, Ying
    Zheng, Yong-Hui
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (03) : 1585 - 1594
  • [24] Promiscuous RNA Binding Ensures Effective Encapsidation of APOBEC3 Proteins by HIV-1
    Apolonia, Luis
    Schulz, Reiner
    Curk, Tomaz
    Rocha, Paula
    Swanson, Chad M.
    Schaller, Torsten
    Ule, Jernej
    Malim, Michael H.
    PLOS PATHOGENS, 2015, 11 (01) : 1 - 22
  • [25] The RNA Binding Specificity of Human APOBEC3 Proteins Resembles That of HIV-1 Nucleocapsid
    York, Ashley
    Kutluay, Sebla B.
    Errando, Manel
    Bieniasz, Paul D.
    PLOS PATHOGENS, 2016, 12 (08)
  • [26] Characterization of routine CEM15, an apobec-1 homolog, that inhibits HIV-1 infection
    Cho, SJ
    Blanc, V
    Davidson, NO
    GASTROENTEROLOGY, 2003, 124 (04) : A472 - A472
  • [27] Reactivation of Latent HIV-1 via AID/APOBEC
    Jose, Diego Pandelo
    Viana Geddes, Victor Emmanuel
    Tanuri, Amilcar
    Aguiar, Renato Santana
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2020, 36 (10) : 793 - 794
  • [28] APOBEC4 Enhances the Replication of HIV-1
    Marino, Daniela
    Perkovic, Mario
    Hain, Anika
    Vasudevan, Ananda A. Jaguva
    Hofmann, Henning
    Hanschmann, Kay-Martin
    Muehlebach, Michael D.
    Schumann, Gerald G.
    Koenig, Renate
    Cichutek, Klaus
    Haeussinger, Dieter
    Muenk, Carsten
    PLOS ONE, 2016, 11 (06):
  • [29] Pharmacologic inhibition of the HIV-1 vif: apobec axis
    Stevenson, Mario
    Rana, Tariq
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 71 : 60 - 60
  • [30] Natural resistance to HIV infection: the Vif-APOBEC interaction
    Malim, Michael H.
    RETROVIROLOGY, 2005, 2 (Suppl 1)